Counterfeit rabies vaccines and rabies immunoglobulin reported overseas

Chief Medical Officer Professor Michael Kidd alerts Australian travellers to recent reports of counterfeit rabies vaccines and rabies immunoglobulin in the Philippines. Counterfeit products have also been reported in India.

Date published:
Audience:
General public

Counterfeit vaccines are products that deliberately misrepresent what they are, what they contain or who made them, including through falsified labels or packaging, and may contain substances that have no medical effect or other active ingredients not intended for use in a rabies vaccine or rabies immunoglobulin product. 

Rabies is a rare but almost always fatal disease once symptoms develop. However, it can be prevented through prompt and appropriate post-exposure treatment. 

People who have received counterfeit rabies vaccines or rabies immunoglobulin may not be adequately protected against rabies. 

The probability that an Australian traveller who received these products overseas will be affected is low. However, because the consequences of inadequate rabies post-exposure treatment can be extremely serious, a precautionary approach is appropriate. 

Australians who received a rabies vaccine or rabies immunoglobulin overseas and are concerned that the product may not have been genuine should speak with a GP or other healthcare provider ahead of any travel to countries where rabies is present. Healthcare providers can review the person’s vaccination and treatment history and advise whether any vaccine doses should be replaced. 

In particular, people who received a rabies vaccine in India on or after 1 November 2023 should seek advice from a healthcare provider about whether replacement doses are required.  

Australians travelling to countries where rabies occurs should: 

  • avoid contact with animals, including dogs, cats, monkeys and bats 
  • immediately and thoroughly wash any bite or scratch with soap and water 
  • seek urgent medical care following a bite, scratch or other possible exposure to animal saliva 
  • obtain rabies vaccines and rabies immunoglobulin from reputable healthcare providers wherever possible 
  • retain detailed records of any treatment received, including the product name, date of administration and batch number 
  • consider taking photographs of the product packaging and label. 

Anyone who has already commenced rabies post-exposure treatment should not delay or discontinue treatment without first seeking advice from a healthcare professional. 

On 5 November 2026 the Australian Technical Advisory Group on Immunisation (ATAGI), issued updated guidance for travellers and healthcare providers. It explains how healthcare providers should assess rabies vaccines and rabies immunoglobulin received overseas when there are concerns that a product may be counterfeit or otherwise invalid. 

I encourage concerned travellers and healthcare providers to read the ATAGI statement on counterfeit rabies vaccines and rabies immunoglobulin,

Professor Michael Kidd AO 

Chief Medical Officer for Australia

Tags: